Skip to main content


Latest articles

24-05-2019 | Diabetes | News | Article

Diabetes patients at high risk of serious NAFLD outcomes

People with non-alcoholic fatty liver disease or non-alcoholic steatohepatitis are at particularly high risk for progression to cirrhosis or hepatocellular carcinoma if they have diabetes, say researchers.

23-05-2019 | Diabetes | News | Article

Treatment simplification a major unmet need in type 1 diabetes

People with type 1 diabetes have high-priority concerns that go beyond glucose control, including complex and mentally taxing treatment and weight gain, report researchers.

22-05-2019 | Diabetes | News | Article

Exome-wide sequencing study sheds light on type 2 diabetes

Researchers have used exome-wide sequencing to identify several rare variants within four genes that are significantly associated with type 2 diabetes.

21-05-2019 | Diabetes | News | Article

CGM still lags behind SMBG during aerobic exercise

Even with newer devices, continuous glucose monitoring underestimates the fall in glucose levels during exercise, with the drop lagging significantly behind that measured by self-monitoring of blood glucose, research shows.

20-05-2019 | Oncology | News | Article

Poor glycemic control linked to prostate cancer progression

In men with prostate cancer and diabetes, higher glycated hemoglobin levels are associated with an increased risk for developing metastases and castration-resistant disease, findings indicate.

17-05-2019 | Diabetes | News | Article

Hypoglycemia on the day of hospital discharge linked to adverse outcomes

Hospitalized individuals with diabetes who have low blood glucose levels on the day of discharge have an elevated risk for readmission and death, findings from a large US cohort study suggest.

17-05-2019 | Diabetes | News | Article

Teen-LABS reports 5-year gains and drawbacks of bariatric surgery in adolescents

Adolescents who undergo bariatric surgery are more likely than adult patients to have remission of diabetes and hypertension, but require more reoperations, show the 5-year outcomes of the Teen-LABS cohort.

15-05-2019 | Diabetes | News | Article

DiRECT/Counterweight-Plus intervention could be cost-effective long-term

Type 2 diabetes remission can be achieved within 1 year at a cost below the average annual cost of diabetes management, even when including complications, shows an economic evaluation of the DiRECT/Counterweight-Plus weight management program.

14-05-2019 | Diabetes | News | Article

Diabetes-related mortality rates are no longer declining

Rates of age-standardized all-cause mortality due to diabetes as the underlying or contributing cause of death have plateaued in recent years following earlier declines, shows an analysis of data from the US Census and national mortality database.

10-05-2019 | Diabetes | News | Article

Late-onset type 1 diabetes frequently misdiagnosed

Research shows that being diagnosed with type 1 diabetes after the age of 30 years is relatively common, yet people are often misdiagnosed with type 2 diabetes, despite rapid progression to insulin dependence.

10-05-2019 | Diabetes | News | Article

Family conflict key factor in poor glycemic control among young insulin users

Factors associated with poor glycemic control in children with type 1 diabetes generally vary according to the insulin regimen used, but family conflict over diabetes management universally impacts all insulin users, US researchers report.

09-05-2019 | Diabetes | News | Article

Support for patch delivery of bolus insulin in people with type 2 diabetes

Delivery of bolus insulin via a patch results in similar glycemic control to that delivered by a conventional pen, with improvements in treatment satisfaction and quality of life, findings from a randomized trial suggest.

08-05-2019 | Diabetes | News | Article

Need for multiple risk factor control highlighted in comorbid diabetes, heart disease

People with diabetes and stable ischemic heart disease are more likely to have long-term survival when they have a greater number of risk factors controlled at prespecified therapeutic goals, research shows.

06-05-2019 | Diabetes | News | Article

Postmarketing data support Fournier gangrene link with SGLT2 inhibitors

Fournier gangrene remains very rare, but is more common in people using SGLT2 inhibitors compared with other diabetes medications and has severe consequences, shows research.

02-05-2019 | Diabetes | News | Article

Metformin may be cardioprotective in patients with coronary artery disease

Findings from the MET-REMODEL trial suggest that metformin treatment may aid regression of left ventricular hypertrophy among nondiabetic patients with coronary artery disease.

01-05-2019 | Diabetes | News | Article

No rush to treat diabetic macular edema with good visual acuity

Research published in JAMA shows similar outcomes for patients with center-involved diabetic macular edema and good visual acuity over the first 2 years after diagnosis, regardless of whether they are managed with aflibercept, laser photocoagulation, or observation.

01-05-2019 | Diabetes | News | Article

Hypoglycemia-prone adults benefit from suspend-before-low pump technology

People with type 1 diabetes at high hypoglycemia risk using insulin pumps have fewer hypoglycemic events if the pump is linked to a continuous glucose monitor and has a suspend-before-low feature, SMILE study data show.

30-04-2019 | Diabetes | News | Article

Benefits of transition support unsustained in young adults with type 1 diabetes

Structured transition support improves clinic attendance, satisfaction with care, and diabetes-related distress in people with type 1 diabetes moving from pediatric to adult care, but only for the duration of the program, Canadian research shows.

29-04-2019 | Diabetes | News | Article

ADVANCE analysis fuels debate on BP targets in type 2 diabetes

A post-hoc analysis of the ADVANCE trial indicates that people with type 2 diabetes may benefit from additional antihypertensive medications even if their blood pressure is already below the 140/90 mmHg target.

29-04-2019 | Diabetes | News | Article

Ellipse trial: Liraglutide expands treatment options for pediatric type 2 diabetes

The Ellipse investigators report improved glycemic control at the price of early and mostly mild gastrointestinal events in children and adolescents with type 2 diabetes.